Human babesiosis in Europe
Human babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Fundação Oswaldo Cruz (FIOCRUZ)
1992-01-01
|
Series: | Memorias do Instituto Oswaldo Cruz |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700019 |
_version_ | 1797702981040209920 |
---|---|
author | P. Brasseur A. Gorenflot |
author_facet | P. Brasseur A. Gorenflot |
author_sort | P. Brasseur |
collection | DOAJ |
description | Human babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in a rural area. Intraerythrocytic pleomorphic parasites (1-3 µm) observed in stained thin blood smears are essential for Genus diagnosis. Parasitemia varyed from 5 to 80% of red blood cells. Massive blood exchange transfusion (2-3 blood volumes) followed by intravenous clindamycine (3-4 times daily) and oral quinine (600 mg base, 3 times daily) were successfully used in the treatment of three recent cases. Splenectomised individuals should be aware for prevention. |
first_indexed | 2024-03-12T04:58:51Z |
format | Article |
id | doaj.art-8e4d54c197bd45d79529d4d0960797ec |
institution | Directory Open Access Journal |
issn | 0074-0276 1678-8060 |
language | English |
last_indexed | 2024-03-12T04:58:51Z |
publishDate | 1992-01-01 |
publisher | Fundação Oswaldo Cruz (FIOCRUZ) |
record_format | Article |
series | Memorias do Instituto Oswaldo Cruz |
spelling | doaj.art-8e4d54c197bd45d79529d4d0960797ec2023-09-03T09:14:36ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80601992-01-018713113210.1590/S0074-02761992000700019Human babesiosis in EuropeP. BrasseurA. GorenflotHuman babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in a rural area. Intraerythrocytic pleomorphic parasites (1-3 µm) observed in stained thin blood smears are essential for Genus diagnosis. Parasitemia varyed from 5 to 80% of red blood cells. Massive blood exchange transfusion (2-3 blood volumes) followed by intravenous clindamycine (3-4 times daily) and oral quinine (600 mg base, 3 times daily) were successfully used in the treatment of three recent cases. Splenectomised individuals should be aware for prevention.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700019human babesiosisBabesia divergensepidemiologytreatment |
spellingShingle | P. Brasseur A. Gorenflot Human babesiosis in Europe Memorias do Instituto Oswaldo Cruz human babesiosis Babesia divergens epidemiology treatment |
title | Human babesiosis in Europe |
title_full | Human babesiosis in Europe |
title_fullStr | Human babesiosis in Europe |
title_full_unstemmed | Human babesiosis in Europe |
title_short | Human babesiosis in Europe |
title_sort | human babesiosis in europe |
topic | human babesiosis Babesia divergens epidemiology treatment |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700019 |
work_keys_str_mv | AT pbrasseur humanbabesiosisineurope AT agorenflot humanbabesiosisineurope |